Krystal Biotech KRYS - Cadena de opciones | ADVFN

US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Krystal Biotech Inc (KRYS)

153.24

-2.51

(-1.61%)

Cerrado 17 Febrero 3:00PM

Delayed by 15 minutes

153.24

-0.37

(-0.24%)

Fuera de horario: 3:03PM

Delayed by 15 minutes

KRYS Flujo de opciones

Calls

Strike	Compra	Venta	Ultimo Precio	P. Medio	Variación	Variación %	Volume	Int Abierto	Último Operado
105.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
110.00	40.00	40.00	40.00	40.00	0.00	0.00 %	0	0	-
115.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
120.00	32.00	36.00	0.00	34.00	0.00	0.00 %	0	0	-
125.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
130.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
135.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
140.00	15.10	18.90	0.00	17.00	0.00	0.00 %	0	0	-
145.00	15.50	15.50	15.50	15.50	0.00	0.00 %	0	2	-
150.00	6.00	6.00	6.00	6.00	0.00	0.00 %	0	1,002	-
155.00	7.43	7.43	7.43	7.43	0.00	0.00 %	0	9	-
160.00	5.78	5.78	5.78	5.78	0.00	0.00 %	0	12	-
165.00	3.92	3.92	3.92	3.92	0.00	0.00 %	0	35	-
170.00	1.10	6.00	6.00	3.55	0.00	0.00 %	0	151	-
175.00	2.10	2.10	2.10	2.10	0.00	0.00 %	0	15	-
180.00	0.65	0.65	0.65	0.65	0.00	0.00 %	0	20	-
185.00	0.05	4.00	1.20	2.025	0.00	0.00 %	0	16	-
190.00	0.05	2.90	0.50	1.475	0.00	0.00 %	0	28	-
195.00	0.15	2.05	1.91	1.10	0.00	0.00 %	0	17	-
200.00	0.61	1.90	0.61	1.255	0.00	0.00 %	0	35	-

Su centro para precios en tiempo real, ideas y debates en vivo

Puts

Strike	Compra	Venta	Ultimo Precio	P. Medio	Variación	Variación %	Volume	Int Abierto	Último Operado
105.00	1.75	1.90	1.75	1.825	0.00	0.00 %	0	1	-
110.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
115.00	3.00	1.00	3.00	2.00	0.00	0.00 %	0	1	-
120.00	0.00	4.80	0.00	0.00	0.00	0.00 %	0	0	-
125.00	0.10	5.00	0.98	2.55	-0.71	-42.01 %	65	1	14/2/2025
130.00	1.60	1.60	1.60	1.60	0.00	0.00 %	0	1,003	-
135.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
140.00	1.90	6.00	1.65	3.95	0.00	0.00 %	0	10	-
145.00	2.75	2.75	2.75	2.75	0.00	0.00 %	0	1	-
150.00	7.22	7.22	7.22	7.22	0.00	0.00 %	0	1,001	-
155.00	7.50	7.50	7.50	7.50	0.00	0.00 %	0	4	-
160.00	11.00	15.00	3.80	13.00	0.00	0.00 %	0	504	-
165.00	4.30	4.30	4.30	4.30	0.00	0.00 %	0	1	-
170.00	18.00	22.50	14.20	20.25	0.00	0.00 %	0	5	-
175.00	14.00	14.00	14.00	14.00	0.00	0.00 %	0	3	-
180.00	23.85	23.85	23.85	23.85	0.00	0.00 %	0	22	-
185.00	22.84	22.84	22.84	22.84	0.00	0.00 %	0	0	-
190.00	29.16	29.16	29.16	29.16	0.00	0.00 %	0	1	-
195.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
JTAIJet AI Inc	US$ 6.02 (133.33%)	101.64M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
WRDWeRide Inc	US$ 31.4877 (83.39%)	20.57M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.67M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	134.88M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	480.49M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	411.17M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
INTCIntel Corporation	US$ 23.60 (-2.20%)	225.04M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	189.56M

Monksdream

Monksdream 4 meses hace

KRYS. Under $200

Monksdream

Monksdream 7 meses hace

KRYS new 52 week high

Monksdream

Monksdream 9 meses hace

KRYS 10Q due 5/6

Monksdream

Monksdream 10 meses hace

Monksdream

Monksdream 11 meses hace

KRYS new 52 week high

Monksdream

Monksdream 2 años hace

From Cathie Wood
A Novel Gene Therapy Promises Relief For A Rare Genetic Skin Disorder
ARK Invest_Illustration_Pierce Jamieson_Final_Circle 400 px By Pierce Jamieson | @PierceARK
Research Associate
Recently, the US Food and Drug Administration (FDA) approved Krysta Biotech’s (KRYS) groundbreaking advance1 in gene therapy, Vyjuvek, to treat wounds in patients suffering from dystrophic epidermolysis bullosa (DEB), a rare and serious genetic skin disorder caused by mutations in the collagen Type VII alpha 1 chain (COL7A1) gene. As the first FDA-approved gene therapy for DEB, Vyjuvek is a significant breakthrough.

Vyjuvek uses a genetically modified HSV-1 to deliver normal copies of the COL7A1 gene to wounds, restoring the integrity of the skin with fibrils that hold skin layers together. Treated with Vyjuvek, 65% of wounds closed completely.

wiredawg

wiredawg 3 años hace

Moving nicely today...

wiredawg

wiredawg 3 años hace

Looking at the few posts here there seems to be no real commitment here...any thoughts on KRYS? Hype or something brewing?

wiredawg

wiredawg 3 años hace

In the last 3 months, 5 ranked analysts set 12-month price targets for KRYS. The average price target among the analysts is $125.00. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price. High $140 Low $111

wiredawg

wiredawg 3 años hace

30 Nov Tues releases this PR during evening after market close:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-pricing-200-million-public-offering

wiredawg

wiredawg 3 años hace

29 Nov Mon after market closes release this PR:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-proposed-200-million-public-offering

wiredawg

wiredawg 3 años hace

29 Nov Monday pre-market news release, great move pre-market approx 7am and so far holding fairly well:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-positive-topline-results-gem-3-pivotal

wiredawg

wiredawg 3 años hace

This caught my eye on Monday, the huge move off the PR...I'm guessing here saw the same. Any real thoughts regarding the company and this PR. I have not gotten a chance to dig into it. Hoping to have somm DD done over the weekend.

wiredawg

wiredawg 3 años hace

Holding well so far, why the pretty hard drop?

wiredawg

wiredawg 3 años hace

Why are you surprised? Serious question, not being impudent...

rynlrt

rynlrt 3 años hace

200 million dollar offering. Won't be surprised to see it drop pretty hard when the market opens

Fofo812

Fofo812 3 años hace

Surprised it held up this long

crudeoil24

crudeoil24 3 años hace

Large tutes holdings. Some taking huge gains before years end.

rynlrt

rynlrt 3 años hace

Not sure this kind of gain is sustainable. May see a big pullback

Fofo812

Fofo812 3 años hace

crudeoil24

crudeoil24 3 años hace

Krystal Biotech shares are trading higher after the company announced its GEM-3 trial met its primary endpoint.

Trophy

Trophy 5 años hace

Krystal Biotech

Nykredit Realkredit

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones